Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05618028 |
|---|---|
| Brief Title: | Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 Tablets |
| First Submitted : | November 14, 2022 |
| First Submitted that Met QC Criteria : | November 14, 2022 |
| First Posted : | November 16, 2022 |
| Last Update Submitted that Met QC Criteria : | April 17, 2024 |
| Last Update Posted : | April 19, 2024 |